These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22290574)

  • 1. Diabetes. Can tight glycemic control in diabetes benefit cognition?
    Herzog RI; Sherwin RS
    Nat Rev Neurol; 2012 Jan; 8(3):124-6. PubMed ID: 22290574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive glucose lowering and cognition in type 2 diabetes.
    Biessels GJ
    Lancet Neurol; 2011 Nov; 10(11):949-50. PubMed ID: 21958948
    [No Abstract]   [Full Text] [Related]  

  • 3. ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial.
    Murray AM; Hsu FC; Williamson JD; Bryan RN; Gerstein HC; Sullivan MD; Miller ME; Leng I; Lovato LL; Launer LJ;
    Diabetologia; 2017 Jan; 60(1):69-80. PubMed ID: 27766347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intensified metabolic control on CNS function in type 2 diabetes.
    Cooray G; Nilsson E; Wahlin A; Laukka EJ; Brismar K; Brismar T
    Psychoneuroendocrinology; 2011 Jan; 36(1):77-86. PubMed ID: 20656408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on: Bosi et al. Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care 2013;36:2887-2894.
    Kleefstra N; Logtenberg SJ; Bilo HJ
    Diabetes Care; 2013 Dec; 36(12):e217. PubMed ID: 24265386
    [No Abstract]   [Full Text] [Related]  

  • 6. The ACCORD Trial and control of blood glucose level in type 2 diabetes mellitus: time to challenge conventional wisdom.
    Havas S
    Arch Intern Med; 2009 Jan; 169(2):150-4. PubMed ID: 19171811
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to comment on: Bosi et al. Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care 2013;36:2887-2894.
    Bosi E; Scavini M; Ceriello A; Cucinotta D; Tiengo A; Marino R; Bonizzoni E; Giorgino F;
    Diabetes Care; 2013 Dec; 36(12):e218. PubMed ID: 24265387
    [No Abstract]   [Full Text] [Related]  

  • 8. The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.
    Ma J; Yang W; Fang N; Zhu W; Wei M
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):596-603. PubMed ID: 19819121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extent of glycemic control in type 2 diabetes mellitus: close, but no cigar.
    Lerch C; Richter B
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):593-5. PubMed ID: 19833492
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
    Tandon N; Ali MK; Narayan KM
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of diabetes in the real world: tight control of glucose metabolism.
    Spellman CW
    J Am Osteopath Assoc; 2003 Aug; 103(8 Suppl 5):S8-13. PubMed ID: 12962204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemia and cognitive function in older adults using glucose-lowering drugs.
    Shorr RI; de Rekeneire N; Resnick HE; Yaffe K; Somes GW; Kanaya AM; Simonsick EM; Newman AB; Harris TB
    J Nutr Health Aging; 2006; 10(4):297-301. PubMed ID: 16886100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age appropriate: Should seniors keep very tight glucose control? That's up for debate.
    Wahowiak L
    Diabetes Forecast; 2013 Aug; 66(8):32-3. PubMed ID: 23967522
    [No Abstract]   [Full Text] [Related]  

  • 16. Improving metabolic control leads to better working memory in adults with type 2 diabetes.
    Ryan CM; Freed MI; Rood JA; Cobitz AR; Waterhouse BR; Strachan MW
    Diabetes Care; 2006 Feb; 29(2):345-51. PubMed ID: 16443885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update - The User's Guide.
    ; Senior PA; Houlden RL; Kim J; Mackay D; Nagpal S; Rabi D; Sherifali D; Bajaj HS
    Can J Diabetes; 2020 Oct; 44(7):592-596. PubMed ID: 32972641
    [No Abstract]   [Full Text] [Related]  

  • 18. Raising serum gastrin to improve glycemic control in (type 2) diabetes: another limb of the enteroinsular axis?
    Rickels MR; Elahi D
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3915-6. PubMed ID: 23129595
    [No Abstract]   [Full Text] [Related]  

  • 19. New therapeutic options: management strategies to optimize glycemic control.
    Sisam DA
    J Am Osteopath Assoc; 2011 Apr; 111(4):300; author reply 300. PubMed ID: 21562302
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical perspectives in type 2 diabetes care: optimizing glycemic control with insulin therapy.
    Diabetes Educ; 2005; Suppl():1-14; quiz 15-6. PubMed ID: 15786628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.